JP2023504186A5 - - Google Patents
Info
- Publication number
- JP2023504186A5 JP2023504186A5 JP2022533064A JP2022533064A JP2023504186A5 JP 2023504186 A5 JP2023504186 A5 JP 2023504186A5 JP 2022533064 A JP2022533064 A JP 2022533064A JP 2022533064 A JP2022533064 A JP 2022533064A JP 2023504186 A5 JP2023504186 A5 JP 2023504186A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- construct
- construct according
- hhhk
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962945042P | 2019-12-06 | 2019-12-06 | |
| US62/945,042 | 2019-12-06 | ||
| PCT/US2020/063676 WO2021113851A2 (en) | 2019-12-06 | 2020-12-07 | Peptide docking vehicle for targeted nucleic acid delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504186A JP2023504186A (ja) | 2023-02-01 |
| JP2023504186A5 true JP2023504186A5 (enExample) | 2024-01-10 |
Family
ID=76222046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533064A Pending JP2023504186A (ja) | 2019-12-06 | 2020-12-07 | 標的化された核酸送達のためのペプチドドッキング賦形剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12054714B2 (enExample) |
| EP (1) | EP4069261A4 (enExample) |
| JP (1) | JP2023504186A (enExample) |
| KR (1) | KR20220115579A (enExample) |
| CN (1) | CN114885604B (enExample) |
| AU (1) | AU2020398192A1 (enExample) |
| BR (1) | BR112022010883A2 (enExample) |
| CA (1) | CA3160576A1 (enExample) |
| IL (1) | IL293589A (enExample) |
| WO (1) | WO2021113851A2 (enExample) |
| ZA (1) | ZA202207211B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114716518A (zh) * | 2021-01-06 | 2022-07-08 | 圣诺制药公司 | 一种能够抑制pcsk9表达的分子构造及药物组合物 |
| EP4380623A4 (en) * | 2021-08-04 | 2026-05-06 | Hepagene Therapeutics Hk Ltd | Ligand conjugates for delivery of therapeutically active agents |
| US20230053360A1 (en) * | 2021-08-11 | 2023-02-23 | Nicholas Stephanopoulos | Nucleic acid-peptide-nucleic acid conjugate molecules and methods of making the same |
| CN118450909A (zh) * | 2021-09-22 | 2024-08-06 | 圣诺制药公司 | 用于制备含有组氨酸-赖氨酸共聚物的纳米颗粒组合物的改善的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101060849A (zh) * | 2004-11-17 | 2007-10-24 | 巴尔的摩马里兰大学 | 作为有效的siRNA载体的高分支HK肽 |
| CA2721183C (en) * | 2008-04-11 | 2019-07-16 | Alnylam Pharmaceuticals, Inc. | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| CA2947904A1 (en) * | 2015-11-12 | 2017-05-12 | Pfizer Inc. | Tissue-specific genome engineering using crispr-cas9 |
| JP2019513371A (ja) * | 2016-04-01 | 2019-05-30 | アビディティー バイオサイエンシーズ エルエルシー | 核酸ポリペプチド組成物とその使用 |
| WO2018013525A1 (en) * | 2016-07-11 | 2018-01-18 | Translate Bio Ma, Inc. | Nucleic acid conjugates and uses thereof |
| RU2019113301A (ru) * | 2016-10-17 | 2020-11-17 | Апеллис Фармасьютикалс, Инк. | Комбинированная терапия для ингибирования с3 |
| AU2019275071B2 (en) * | 2018-05-24 | 2022-12-15 | Sirnaomics, Inc. | Composition and methods of controllable co-coupling polypeptide nanoparticle delivery system for nucleic acid therapeutics |
-
2020
- 2020-12-07 US US17/114,443 patent/US12054714B2/en active Active
- 2020-12-07 AU AU2020398192A patent/AU2020398192A1/en not_active Abandoned
- 2020-12-07 WO PCT/US2020/063676 patent/WO2021113851A2/en not_active Ceased
- 2020-12-07 IL IL293589A patent/IL293589A/en unknown
- 2020-12-07 JP JP2022533064A patent/JP2023504186A/ja active Pending
- 2020-12-07 CN CN202080072338.1A patent/CN114885604B/zh active Active
- 2020-12-07 CA CA3160576A patent/CA3160576A1/en active Pending
- 2020-12-07 EP EP20896972.5A patent/EP4069261A4/en not_active Withdrawn
- 2020-12-07 BR BR112022010883A patent/BR112022010883A2/pt not_active IP Right Cessation
- 2020-12-07 KR KR1020227021748A patent/KR20220115579A/ko active Pending
-
2022
- 2022-06-29 ZA ZA2022/07211A patent/ZA202207211B/en unknown